BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524703

SANDUPHQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SANDU PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, SANDU PHARMACEUTICALS LTD. share price is currently at ₹ 44.99, which is up by ₹ 0.23 from its previous closing. Today, the stock has fluctuated between ₹ 44.99 and ₹ 46.00. Over the past year, SANDU PHARMACEUTICALS LTD. has achieved a return of -19.22 %. In the last month alone, the return has been -4.03 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SANDU PHARMACEUTICALS LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    43.50

  • P/E Ratio (TTM)

    26.96

  • Beta

    0.83

  • Book Value / share

    34.62

  • Return on equity

    4.74%

  • EPS (TTM)

    1.66

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.22

info icon alternate text

SANDU PHARMACEUTICALS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 16.70
Operating Expense 16.38
Net Profit 0.22
Net Profit Margin (%) 1.31
Earnings Per Share (EPS) 0.23
EBITDA 0.55
Effective Tax Rate (%) 35.29
Particulars MAR 2025 (Values in Cr)
Revenue 14.07
Operating Expense 13.79
Net Profit 0.33
Net Profit Margin (%) 2.34
Earnings Per Share (EPS) 0.34
EBITDA 0.52
Effective Tax Rate (%) 5.88
Particulars DEC 2024 (Values in Cr)
Revenue 18.37
Operating Expense 17.60
Net Profit 0.56
Net Profit Margin (%) 3.04
Earnings Per Share (EPS) 0.57
EBITDA 1.02
Effective Tax Rate (%) 30.00
Particulars SEP 2024 (Values in Cr)
Revenue 17.70
Operating Expense 16.99
Net Profit 0.50
Net Profit Margin (%) 2.82
Earnings Per Share (EPS) 0.52
EBITDA 0.94
Effective Tax Rate (%) 32.43
Particulars JUN 2024 (Values in Cr)
Revenue 17.05
Operating Expense 16.82
Net Profit 0.17
Net Profit Margin (%) 0.99
Earnings Per Share (EPS) 0.17
EBITDA 0.45
Effective Tax Rate (%) 37.03
Particulars MAR 2025 (Values in Cr)
Revenue 67.19
Operating Expense 65.19
Net Profit 1.55
Net Profit Margin (%) 2.30
Earnings Per Share (EPS) 1.60
EBITDA 2.93
Effective Tax Rate (%) 28.24
Particulars MAR 2024 (Values in Cr)
Revenue 67.28
Operating Expense 65.63
Net Profit 1.46
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 1.51
EBITDA 2.71
Effective Tax Rate (%) 29.46
Particulars MAR 2023 (Values in Cr)
Revenue 65.35
Operating Expense 63.46
Net Profit 1.52
Net Profit Margin (%) 2.32
Earnings Per Share (EPS) 1.62
EBITDA 2.82
Effective Tax Rate (%) 31.53
Particulars MAR 2022 (Values in Cr)
Revenue 65.50
Operating Expense 63.26
Net Profit 1.59
Net Profit Margin (%) 2.42
Earnings Per Share (EPS) 1.99
EBITDA 2.96
Effective Tax Rate (%) 31.46
Particulars MAR 2021 (Values in Cr)
Revenue 58.76
Operating Expense 57.26
Net Profit 1.09
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 1.54
EBITDA 2.35
Effective Tax Rate (%) 35.11
Particulars MAR 2025 (Values in Cr)
Book Value / Share 34.63
ROE % 4.74
ROCE % 6.87
Total Debt to Total Equity 0.00
EBITDA Margin 4.36
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.01
ROE % 4.11
ROCE % 5.98
Total Debt to Total Equity 0.00
EBITDA Margin 4.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 40.62
ROE % 3.87
ROCE % 5.86
Total Debt to Total Equity 0.00
EBITDA Margin 4.30
Particulars MAR 2025 (Values in Cr)
Book Value / Share 34.63
ROE % 4.74
ROCE % 6.87
Total Debt to Total Equity 0.00
EBITDA Margin 4.36
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.01
ROE % 4.11
ROCE % 5.98
Total Debt to Total Equity 0.00
EBITDA Margin 4.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 40.62
ROE % 4.56
ROCE % 6.89
Total Debt to Total Equity 0.00
EBITDA Margin 4.32
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.71
ROE % 6.13
ROCE % 9.37
Total Debt to Total Equity 0.00
EBITDA Margin 4.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.63
ROE % 4.92
ROCE % 7.85
Total Debt to Total Equity 0.03
EBITDA Margin 4.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.65
Total Assets 55.71
Total Liabilities 55.71
Total Equity 42.01
Share Outstanding 9660990
Price to Book Ratio 1.41
Return on Assets (%) 2.78
Return on Capital (%) 3.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.20
Total Assets 52.41
Total Liabilities 52.41
Total Equity 40.59
Share Outstanding 9660990
Price to Book Ratio 1.74
Return on Assets (%) 2.78
Return on Capital (%) 3.6
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.29
Total Assets 54.16
Total Liabilities 54.16
Total Equity 39.24
Share Outstanding 9660990
Price to Book Ratio 1.29
Return on Assets (%) 2.80
Return on Capital (%) 3.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.65
Total Assets 55.71
Total Liabilities 55.71
Total Equity 42.01
Share Outstanding 9660990
Price to Book Ratio 1.41
Return on Assets (%) 2.77
Return on Capital (%) 3.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 52.41
Total Liabilities 52.41
Total Equity 40.59
Share Outstanding 9660990
Price to Book Ratio 1.74
Return on Assets (%) 2.78
Return on Capital (%) 3.6
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.28
Total Assets 54.16
Total Liabilities 54.16
Total Equity 39.24
Share Outstanding 9660990
Price to Book Ratio 1.29
Return on Assets (%) 2.81
Return on Capital (%) 3.88
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.17
Total Assets 49.28
Total Liabilities 49.28
Total Equity 36.47
Share Outstanding 8810664
Price to Book Ratio 2.29
Return on Assets (%) 3.22
Return on Capital (%) 4.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.65
Total Assets 46.96
Total Liabilities 46.96
Total Equity 33.49
Share Outstanding 7920997
Price to Book Ratio 1.08
Return on Assets (%) 2.32
Return on Capital (%) 3.26
Particulars MAR 2025 (Values in Cr)
Net Income 2.15
Cash from Operations 1.53
Cash from Investing -0.18
Cash from Financing -0.46
Net change in Cash 0.30
Free Cash Flow 2.46
Particulars MAR 2024 (Values in Cr)
Net Income 2.07
Cash from Operations 1.25
Cash from Investing -1.30
Cash from Financing -0.72
Net change in Cash -1.27
Free Cash Flow 2.68
Particulars MAR 2023 (Values in Cr)
Net Income 2.21
Cash from Operations 0.92
Cash from Investing 0.53
Cash from Financing 0.57
Net change in Cash 1.33
Free Cash Flow 1.98
Particulars MAR 2025 (Values in Cr)
Net Income 2.15
Cash from Operations 1.53
Cash from Investing -0.17
Cash from Financing -0.46
Net change in Cash 0.30
Free Cash Flow 2.47
Particulars MAR 2024 (Values in Cr)
Net Income 2.07
Cash from Operations 1.26
Cash from Investing -1.30
Cash from Financing -0.72
Net change in Cash -1.27
Free Cash Flow 2.68
Particulars MAR 2023 (Values in Cr)
Net Income 2.22
Cash from Operations 0.92
Cash from Investing 0.52
Cash from Financing 0.57
Net change in Cash 1.32
Free Cash Flow 1.98
Particulars MAR 2022 (Values in Cr)
Net Income 2.31
Cash from Operations 1.82
Cash from Investing -5.47
Cash from Financing 0.93
Net change in Cash -3.58
Free Cash Flow 2.66
Particulars MAR 2021 (Values in Cr)
Net Income 1.68
Cash from Operations 8.04
Cash from Investing -5.57
Cash from Financing 1.29
Net change in Cash 3.31
Free Cash Flow 8.17
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 13.29 1.78 249.44 30.00 / 68.00
BLISS GVS PHARMA LTD 156.60 15.52 1.57 1654.47 105.05 / 190.65
CIPLA LTD 1501.65 22.29 3.68 121298.96 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 275.65 7.76 2.23 811.27 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 17.69 5.14 249.44 30.00 / 68.00
AMRUTAJAN HEALTH LTD 724.70 38.43 6.41 2095.15 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9535.45 112.73 30.94 23838.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 156.60 23.44 1.56 1654.47 105.05 / 190.65

SANDU PHARMACEUTICALS LTD. shareholding pattern

Holding

Others
57.09%
Promoter Holdings
42.9%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Umesh Bhaskar Sandu 1388693.0 (14.37%) Shareholding of Promoter and Promoter Group
Shashank Bhaskar Sandu 1368755.0 (14.17%) Shareholding of Promoter and Promoter Group
Jayshree Bhaskar Sandu 737000.0 (7.63%) Shareholding of Promoter and Promoter Group
Sanmark Realty And Finance Private Limited 543930.0 (5.63%) Public Shareholding
Akshath Finvest And Properties Private Limited 494182.0 (5.12%) Shareholding of Promoter and Promoter Group
Tanvi Jignesh Mehta 455360.0 (4.71%) Public Shareholding
Neelamber Leasing And Finvest Private Limited 455495.0 (4.71%) Public Shareholding
Sanbro Marketing Services Pvt Ltd 250000.0 (2.59%) Public Shareholding
Noumura Realty And Constructions Private Limited 219010.0 (2.27%) Public Shareholding
Phybrichem Engineers Private Limited 155963.0 (1.61%) Public Shareholding
Hitesh Kuvelkar 121427.0 (1.26%) Public Shareholding
Geeta U Sandu 85000.0 (0.88%) Shareholding of Promoter and Promoter Group
Minal Shashank Sandu 61100.0 (0.63%) Shareholding of Promoter and Promoter Group
Shubhada Prabhakar Sandu 10000.0 (0.1%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

SANDU PHARMACEUTICALS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
44.99 0.51 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 44.30
  • 26 Days 45.00
  • 10 Days 44.30
  • 50 Days 46.10
  • 12 Days 44.40
  • 100 Days 47.80
  • 20 Days 44.70
  • 200 Days 50.30
44.12 PIVOT

First Support

43.36

First Resistance

44.75

Second Support

42.73

Second Resistance

45.51

Third Support

41.97

Third Resistance

46.14

RSI

47.53

ADX

71.62

MACD

-0.68

Williams % R

-35.77

Commodity Channel Index (CCI)

-14.67

Date

2025-10-31

Week

2612.00

Same Day

3657.00

Month

1955.00

1 Year

0.84

3 Year

0.57

Over 1 Month

-4.03%

down

Over 1 Year

-19.22%

down

Over 3 Months

-9.17%

down

Over 3 Years

-12.07%

down

Over 6 Months

-10.88%

down

Over 5 Years

8.73%

down

SANDU PHARMACEUTICALS LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 0.8 Final 18 Sep 2025 Equity shares
19 Sep 2024 0.8 Final 20 Sep 2024 Equity shares
18 Sep 2023 0.75 Final 19 Sep 2023 Equity shares
23 Sep 2022 0.75 Final 23 Sep 2022 Equity shares
22 Sep 2021 0.5 Final 24 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SANDU PHARMACEUTICALS LTD. Share Price

Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU.

SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.

The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

Parent organization Indian Private
NSE symbol [-]
Founded 1985
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sandu Pharmaceuticals Ltd?

Answer Field

Sandu Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 44.99 as on Nov 03 2025 11:52 AM.

What is the Market Cap of Sandu Pharmaceuticals Ltd Share?

Answer Field

The market cap of Sandu Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 43.50 as on Nov 03 2025 11:52 AM.

What is the 52 Week High and Low of Sandu Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Sandu Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 62.80 and ₹ 43.00.

What is 1 year return for Sandu Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -19.22%.

What is the P/E Ratio of Sandu Pharmaceuticals Ltd Share?

Answer Field

As on Nov 03 2025 11:52 AM the price-to-earnings (PE) ratio for Sandu Pharmaceuticals Ltd share is 26.96.

What is the PB ratio of Sandu Pharmaceuticals Ltd Share?

Answer Field

As on Nov 03 2025 11:52 AM, the price-to-book (PB) ratio for Sandu Pharmaceuticals Ltd share is 34.62.

How to Buy Sandu Pharmaceuticals Ltd Share?

Answer Field

You can trade in Sandu Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sandu Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Sandu Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sandu Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59